Search

Your search keyword '"Nacev, A."' showing total 572 results

Search Constraints

Start Over You searched for: Author "Nacev, A." Remove constraint Author: "Nacev, A."
572 results on '"Nacev, A."'

Search Results

2. Author Correction: Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation

3. Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation

4. THE 2022 NATO MADRID SUMMIT AND THE NEW STRATEGIC CONCEPT PROVISIONS

5. Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation

6. Author Correction: Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation

7. Differences between rural and urban residence in the detection and treatment of perinatal mood and anxiety disordersAJOG Global Reports at a Glance

9. Detection of Alternative Lengthening of Telomeres via Chromogenic In Situ Hybridization for the Prognostication of PanNETs and Other Neoplasms

10. Stereotactic body radiation therapy for sarcoma pulmonary metastases

13. GLOBAL SECURITY TRENDS IN EURO-ATLANTIC AREA AND NATO NEW STRATEGIC CONCEPT

14. Factors Influencing Provider Behavior Around Delivery of Preconception Care

15. Adapting Patient Experience Data Collection Processes for Lower Literacy Patient Populations Using Tablets at the Point of Care

16. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

17. Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma

19. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

20. Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma

22. ENGAGEMENT OF THE ARMED FORCES IN SUPPORT OF CIVILIAN AUTORITIES IN CRISIS SITUATION AND STATE OF EMERGENCY

26. Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

29. Immune checkpoint inhibitor response in sarcomas associates with immune infiltrates and increased expression of transposable elements and viral response pathways

30. The epigenomics of sarcoma

32. Traumatic ventricular septal defect resulting in severe pulmonary hypertension.

33. Managing Patients With Unlabeled Passive Implants on MR Systems Operating Below 1.5 T.

35. Supplementary Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

36. TABLE 3 from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

37. TABLE 4 from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

38. Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

39. TABLE 2 from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

40. TABLE 1 from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

41. Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

42. Teasing among School-Age Children.

45. The expanding landscape of 'oncohistone' mutations in human cancers

47. Medical management of hepatic ectopic pregnancy with systemic methotrexate, MRI and serial HCG monitoring

50. Supplementary Data 2 from A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma

Catalog

Books, media, physical & digital resources